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OBJECTIVES The purpose of this study was to determine the short-term effects of transmyocardial laser
revascularization (TMR) on regional left ventricular systolic and diastolic function, myocar-
dial blood flow (MBF) and myocardial water content (MWC).
BACKGROUND Clinical studies of TMR have noted a significant incidence of cardiac complications in the
early postoperative period. However, the early post-treatment effects of laser therapy on the
myocardium and their potential contribution to postoperative cardiac morbidity are unknown.
METHODS Swine underwent holmium:yttrium-aluminum-garnet (holmium:YAG) (n 5 12) or carbon
dioxide (CO2) (n 5 12) laser TMR. Regional systolic function for the lased and nonlased
regions was quantitated using preload recruitable work area (PRWA) and regional diastolic
function with the ventricular stiffness constant alpha.
RESULTS Preload recruitable work area was significantly decreased in the lased regions both 1 (59.8 6
13.0% of baseline, p 5 0.02) and 6 h (64.2 6 9.4% of baseline, p 5 0.02) after holmium:YAG
TMR. This decreased PRWA was associated with a significant reduction in MBF to the lased
regions (13.2% reduction at 1 h, p 5 0.02; 18.4% decrease at 6 h post-TMR, p 5 0.01).
These changes were not seen after CO2 laser TMR. A significant increase in MWC (1.4 6
0.3% increase with holmium:YAG, p 5 0.004; 1 6 0.2% increase with CO2, p 5 0.002) and
alpha (217.4 6 44.2% of baseline 6 h post-holmium:YAG TMR, p 5 0.05; 206 6 36.7% of
baseline 6 h post-CO2 TMR, p 5 0.03) was seen after TMR with both lasers.
CONCLUSIONS In the early postoperative setting, impaired regional systolic function in association with
regional ischemia is seen after TMR with a holmium:YAG laser. Both holmium:YAG and
CO2 lasers are associated with increased MWC and impaired diastolic relaxation in the lased
regions. These changes may explain the significant incidence of early postoperative cardiac
morbidity. The impact of these findings on anginal relief and long-term outcome are not
known. (J Am Coll Cardiol 2000;35:1022–30) © 2000 by the American College of
Cardiology
Transmyocardial laser revascularization (TMR) is emerging
as a potential treatment option in end stage coronary artery
disease (1–8). The procedure involves using a high powered
laser to create transmural channels from the epicardial to
endocardial surface of the left ventricular free wall in regions
of chronically ischemic yet viable myocardium. Most com-
monly, the procedure is performed through a small antero-
lateral thoracotomy although reports of thoracoscopic TMR
are increasing (9,10). In addition, the procedure has been
suggested as a potential treatment option in an expanding
array of clinical settings including cardiac allograft vascu-
lopathy (11,12) and for use in combined procedures with
percutaneous transluminal coronary angioplasty (PTCA)
(13), coronary artery bypass grafting (CABG) (6,13) and
valve replacement (14). Clinical studies have consistently
demonstrated significant reductions in anginal class after the
procedure although these benefits are usually not apparent
until at least 3 months postoperatively (1–7). The mecha-
nism of action of TMR may potentially be mediated via
angiogenesis (15,16), and the time needed for new blood
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vessel growth might account for the delay in clinical
improvement after the procedure.
Because the benefits of TMR are delayed, patients
undergoing the procedure appear to be at high risk for
postoperative complications. Clinical studies of TMR have
noted the majority of these adverse events to be cardiac in
nature, primarily ischemia and congestive heart failure
(1–4,8,13,17–19). However, the degree to which these
complications potentially stem from direct myocardial injury
after laser application is unknown. Consequently, the pur-
pose of this study was to determine the early postoperative
effects of TMR on regional left ventricular systolic and
diastolic function, myocardial blood flow (MBF) and myo-
cardial water content (MWC). Because most clinical studies
to date have used either carbon dioxide (CO2) (1–4,7,8,13)
or holmium:yttrium-aluminum-garnet (holmium:YAG)
(5,6) laser energy for channel production and because both
are now FDA approved for the treatment of medically
refractory angina in patients with end stage coronary dis-
ease, these were chosen for this study.
METHODS
A total of 24 crossbred swine (50 kg) were used. Animals
were obtained from Walnut Hill Farms (Hillsborough,
North Carolina), housed under standard conditions and fed
a regular diet. The Animal Care and Use Committee of
Duke University approved all procedures and protocols.
Animals received humane care in compliance with the
“Principles of Laboratory Animal Care” formulated by the
National Society for Medical Research and the “Guide for
the Care and Use of Laboratory Animals” prepared by the
Institute of Laboratory Animal Resources and published by
the National Institutes of Health (NIH publication 85-23,
revised 1985).
Experimental preparation. All animals underwent induc-
tion of anesthesia with ketamine (22 mg/kg IM) and
diazepam (10 mg IV). Orotracheal intubation was per-
formed and anesthesia maintained with continuous infu-
sions of diazepam (15 mg/h IV) and fentanyl (30 mg/kg/h
IV) while the animals were mechanically ventilated (20).
Additional doses of IV fentanyl and diazepam were given
throughout the experiment as needed. Bretylium tosylate
(5 mg/kg IV) was given preoperatively to prevent cardiac
arrhythmias (20). An 8 Fr introducer sheath was placed in
the left carotid artery with its tip in the aorta. The sheath
was used for continuous arterial blood pressure monitoring
during the experiment and as the reference standard with-
drawal port during injection of radioactive microspheres as
described below. A 16-gauge angiocatheter was placed in
the left anterior jugular vein for administering drugs and
fluids. A median sternotomy was performed and the heart
suspended in a pericardial cradle. Pneumatic occluders were
placed about the superior and inferior vena cavae. Pairs of
ultrasonic dimension transducers were implanted in the
subendocardium of the anterolateral (region to be lased) and
posterolateral (control region) left ventricular free walls to
assess regional myocardial segment length. Transducers
were aligned 10 to 15 mm apart along the circumference of
the minor axis of the left ventricle. A flexible 19-gauge
catheter was placed in the base of the left atrial appendage
for microsphere injections (Fig. 1). A micromanometer
(Millar Instruments Inc., Model PC-350, Houston, Texas)
was balanced, calibrated and passed into the left ventricle via
the apex. Continuous electrocardiographic monitoring was
used throughout the procedure to ensure a stable cardiac
rhythm. Serial blood gas analysis was used to ensure
adequate oxygenation and ventilation. Ventilator settings
were adjusted to maintain pH 7.35–7.45 and pO2 $
100 mm Hg. Body temperature was monitored and main-
tained at 37°C. Ringer’s lactate was infused at a rate of
5 ml/kg/h during the course of the experiment (20).
Regional function data collection and analysis. Regional
systolic contractile function was assessed using the preload
recruitable work area (PRWA), a load insensitive index of
regional myocardial performance (21,22). Data were col-
lected at baseline, 1 and 6 h after TMR in anesthetized
animals. Data collection was performed under steady-state
conditions during rapid vena caval occlusion to obtain data
over a range of loading conditions.
The analog data were filtered by a 50 Hz low-pass filter
and digitized in real time at an eight-channel sweep rate of
200 Hz by an analog to digital converter (ADAC model
1012, Woburn, Massachusetts). After data collection, anal-
ysis was performed on a microprocessor (MicroVAX II/
GPX Work Station, Digital Equipment Corp., Maynard,
Massachusetts) with custom interactive programs (Physio-
logic Monitoring Inc., Durham, North Carolina). The first
derivative of left ventricular transmural pressure (dP/dt) was
calculated from the digital pressure waveform as a running
five-point polyorthogonal transformation.
The cardiac cycle was defined automatically using dP/dt
Abbreviations and Acronyms
ANOVA 5 analysis of variance
CABG 5 coronary artery bypass grafting
CO2 5 carbon dioxide
dP/dt 5 first derivative of left ventricular
transmural pressure
EDL 5 end diastolic segment length
holmium:YAG 5 holmium:yttrium-aluminum-garnet
l 5 regional segment length
MBF 5 myocardial blood flow
MWC 5 myocardial water content
PRSW 5 preload recruitable stroke work
PRWA 5 preload recruitable work area
PTCA 5 percutaneous transluminal coronary
angioplasty
SW 5 stroke work
TMR 5 transmyocardial laser revascularization
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as described previously (21,22). Diastole was defined as
beginning 15 ms after the first zero crossing of dP/dt after
peak negative dP/dt and ending 15 ms before the beginning
of the systolic upstroke of left ventricular pressure. Begin-
ning ejection was placed at peak positive dP/dt and end
ejection defined as peak negative dP/dt. Beat point defini-
tions were visually confirmed on all data with a videograph-
ics display system.
An analog of segmental stroke work (SW) was then
calculated as the integral of left ventricular pressure (P) and
myocardial segment length (L) over each cardiac cycle
according to the following equation:
SW 5 *PdL.
For each vena caval occlusion, linear regressions were
performed on data from 10 beats before onset of vena caval
occlusion to achievement of steady state at end vena caval
occlusion (,0.5% beat-to-beat change in segment length at
beginning diastole). Only data where heart rate changed by
,10% were considered.
Data obtained during transient vena caval occlusion were
fitted to the regional preload recruitable stroke work
(PRSW) relationship relating SW to end-diastolic segment
length (EDL) (21):
SW 5 MSW (EDL 2 LW)
where MSW and LW are the slope and relationship
x-intercept, respectively. Preload recruitable work area, a
normalized index of contractility defined as the area under
the SW versus EDL regression line, was calculated from the
formula:
PRWA 5 MSW/2 (1.2 LWmax 2 LW)2
where LWmax is the maximal x-intercept obtained for a
given myocardial segment over the entire experiment. The
factor 1.2 was chosen so that PRWA was always positive but
still diminished significantly as LW approached LWmax
(21,22).
Steady-state pressure and segment length relations during
diastole were used to quantify regional diastolic function.
Regional segment length (l) was normalized as Lagrangian
strain (epsilon) using the equation (23):
« 5 ~l 2 l0!/l0
where l0 is the unstressed segment length obtained from
maximal vena caval occlusion. Static pressure-strain rela-
tions during the passive filling phase of diastole were then
fitted to a monoexponential equation:
P 5 beae 1 P0
where P is left ventricular pressure and both a and b are
constants that reflect regional material properties. For the
purposes of this study, a was chosen to compare changes in
regional myocardial stiffness during diastole (24,25).
All steady-state data are reported as mean values over 10
to 20 cardiac cycles. Slopes, intercepts and linear correlation
coefficients were derived from least squares regression pro-
cedures.
MBF measurements. Myocardial blood flow in the lased
and control regions was determined 1 and 6 h after TMR by
injecting radionuclide-labeled microspheres by the reference
withdrawal method (26). For each blood flow determina-
tion, approximately 1 3 106 microspheres of 15 mm
diameter labeled with one of two different isotopes (95Nb,
103Ru) (New England Nuclear, Boston, Massachusetts)
were injected via the left atrial line. Each dose of micro-
spheres was injected via the left atrial catheter within
approximately 5 s and then flushed with 10 cc of saline. The
arterial reference sample was withdrawn via the carotid
catheter at a constant rate of 5 ml/min beginning before
microsphere injection and continuing for 3 min. Micro-
sphere suspensions were vortex agitated followed by warm
water sonication for at least 30 min before injection,
according to manufacturer recommendations. Injections of
microspheres presented herein resulted in no changes in
heart rate, blood pressure, left ventricular pressure or left
ventricular wall dimensions. The myocardial and reference
blood samples were counted in a Packard Auto-Gamma
Figure 1. Experimental preparation demonstrating pairs of in-
tramyocardial dimension transducers in region undergoing TMR
(anterolateral left ventricular free wall) and control region (pos-
terolateral left ventricular free wall). Fifteen transmural TMR
channels were placed at 1 cm intervals in lased region. Care was
taken to avoid all epicardial and intramyocardial vessels. Also
shown is the left atrial catheter used for injection of radioactive
microspheres. Superior and inferior vena caval occluders and left
ventricular pressure transducer not shown. TMR 5 transmyocar-
dial laser revascularization.
1024 Hughes et al. JACC Vol. 35, No. 4, 2000
Regional Function After TMR March 15, 2000:1022–30
5000 Series Gamma Counter (Downers Grove, Illinois) at
an optimum window setting selected to correspond to the
peak energies of each nuclide. The counts per min recorded
in each window were corrected for background activity
contributed by the accompanying isotopes. Flow to the lased
and control myocardium was calculated using the following
equation:
Q m 5 (Cm 3 Q r)/(Cr 3 Wd)
where Q m 5 MBF per g dry tissue weight (ml/min/g),
Cm 5 counts per min in tissue sample, Q r 5 withdrawal
rate of the reference blood sample (ml/min), Cr 5 counts
per min in the withdrawal blood sample and Wd 5 dry
tissue weight of region (g). Pilot studies demonstrated no
difference in baseline Q m between the anterolateral (lased
regions) and posterolateral (control regions) left ventricular
myocardium in this animal model. Blood flow was calcu-
lated per g of dry tissue weight to minimize the potential for
laser induced myocardial edema to spuriously lower mea-
surements of MBF via increasing the value of regional tissue
weight in the denominator of the above formula. Methods
for determining dry tissue weight for the lased and control
regions are presented below.
TMR. A holmium:YAG (Cardiogenesis, Inc., Sunnyvale,
California) (n 5 12) or 800 W CO2 laser (PLC Medical
Systems, Inc., Milford, Massachusetts) (n 5 12) was used to
create 15 channels at 1 cm intervals in the anterolateral wall
of the left ventricle (Fig. 1). Animals were randomly
assigned to each laser group. Care was taken to avoid all
epicardial and intramyocardial vessels. Carbon dioxide laser
channels were created using a single 40 J pulse (50 ms pulse
duration), whereas holmium:YAG channels were created
using multiple 2 J pulses, with a total energy level of
approximately 20 J per channel. All laser settings were in
accordance with manufacturer recommendations. Transmu-
ral penetration of laser channels was confirmed by visible
spurting of blood from the channels during systole. Hemo-
stasis was obtained by manual compression. One and 6 h
post-TMR, measurements of regional myocardial function
and MBF were collected as described above.
Tissue water content measurements. Animals were sacri-
ficed under general anesthesia after collection of the 6-h
post-TMR data. Hearts were harvested and the anterolat-
eral wall region containing the TMR channels was excised,
blotted dry and weighed. The presence of transmural
penetration of the laser channels was confirmed grossly at
this time. The nonlased posterolateral wall control region
was likewise excised and weighed. After measurement of the
wet weight of the lased and control regions, they were dried
at 65°C for 72 h and reweighed (27). Myocardial water
content (MWC) was calculated as follows (28):
@~wet weight 2 dry weight!/wet weight# 3 100%.
Statistical analysis. All data were analyzed in a blinded
fashion. Statistical comparisons were performed using
STATISTICA for windows version 5.1 (StatSoft, Inc.,
Tulsa, Oklahoma). All data is presented as the mean 6
standard error. Serial measurements of hemodynamic data,
PRWA and regional diastolic stiffness over time throughout
the experiment were compared using a one-way analysis of
variance (ANOVA) test. When overall significance was
found within the ANOVA, Newman-Keuls test was used to
delineate which comparisons were significantly different
(29). Values of MBF and water content were compared for
lased and nonlased regions using a paired Student t test.
Changes in percent tissue water content were compared
between holmium:YAG and CO2 lased regions using an
unpaired Student t test. Statistical significance was consid-
ered a p value ,0.05.
RESULTS
Hemodynamics. Mean baseline, 1 h and 6-h post-TMR
global hemodynamic and arterial pH data for all animals is
presented in Table 1. As analyzed using a one-way
ANOVA, there was no significant difference in any of the
hemodynamic parameters measured at any time point dur-
ing the study. This held true when all of the animals were
grouped together, as in Table 1, and when the holmium:
YAG and CO2 groups were compared individually (data not
shown).
Regional left ventricular function. Digitized data for a
representative study at baseline, 1 h and 6 h post-TMR is
shown in Figure 2. Representative regional SW versus
end-diastolic segment length curves used to derive PRWA
are shown in Figure 3. Preload recruitable work area, a
load-insensitive index of regional myocardial contractile
function, was significantly reduced in the lased regions at
both 1 and 6 h after TMR with a holmium:YAG laser (Fig.
Table 1. Hemodynamic and pH Data*
Heart
Rate MAP LVEDP pH
Baseline 101 6 5 93 6 6 2.4 6 0.9 7.41 6 0.01
1 h Post-TMR 100 6 7 90 6 4 2.8 6 0.9 7.40 6 0.01
6 h Post-TMR 85 6 5 91 6 5 3.3 6 1.2 7.43 6 0.01
*There was no statistically significant difference between any of the measured parameters at any time point during the study.
LVEDP 5 left ventricular end-diastolic pressure; MAP 5 mean arterial pressure; TMR 5 transmyocardial laser
revascularization.
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4A). There was no change in the PRWA of control
nonlased regions in the holmium:YAG group. Likewise,
there was no significant change in the PRWA of the lased
or control regions after TMR with a CO2 laser (Fig. 4B).
Representative regional steady-state pressure-strain rela-
tions during diastole for the lased region in a single animal
at baseline, 1 h and 6 h post-TMR are shown in Figure 5.
By 6 h postoperatively, regional diastolic relaxation was
significantly impaired in regions treated with both
holmium:YAG and CO2 lasers (Fig. 6). In both groups,
alpha 6 h post-TMR was more than double its baseline
value, indicating a two-fold increase in regional myocardial
stiffness. No change in diastolic relaxation was seen in the
nonlased regions of hearts treated with either laser.
Regional MBF. Absolute values of MBF per g dry tissue
weight for the lased and nonlased regions are presented in
Table 2. There was a statistically significant decrease in
transmural MBF in the regions lased with a holmium:YAG
laser both 1 and 6 h post-TMR. This reduction in trans-
mural blood flow (13.2% decrease at 1 h and 18.4% decrease
at 6 h post-TMR) potentially explains the observed impair-
ment in systolic function, as evidenced by a significant
decrease in PRWA, in the holmium:YAG lased regions. No
significant change in MBF was seen in the CO2 treated
regions, which correlates with the functional data as well
since no change in PRWA was seen in the CO2 lased
hearts.
Tissue water content. Changes in MWC after TMR are
presented in Table 3. Values of MWC in the nonlased
control regions are consistent with normal values found in
pigs by prior investigators (25,28). Overall, there was a
1.4 6 0.3% increase in MWC in regions lased with a
holmium:YAG laser over the corresponding nonlased re-
gions. Likewise, there was a 1 6 0.2% increase in tissue
water in CO2 lased regions. The increased myocardial
edema in regions treated with holmium:YAG versus CO2
laser trended towards, but did not reach, statistical signifi-
cance (p 5 0.13). These findings likely explain the impaired
diastolic relaxation observed in the lased regions after TMR
with both lasers (25,28).
DISCUSSION
Transmyocardial laser revascularization is emerging as a
potential treatment strategy for thousands of patients with
ischemic heart disease not amenable to CABG or PTCA.
However, despite the apparently increasing use of the
procedure, the direct effects of the more commonly used
lasers on myocardial function have been incompletely char-
acterized. Prior studies of post-TMR function have used
either load sensitive indexes of contractile performance
without specifically controlling loading conditions
(8,30,31), channel densities much greater than utilized
clinically today (30–32) or have created nontransmural
channels (30,32). In addition, no study to date has examined
MWC and diastolic function after TMR. This study is the
first to fully describe the early postoperative effects of both
holmium:YAG and CO2 lasers on regional left ventricular
systolic and diastolic function, MBF and tissue water
content. The major findings of the study are that, in the
early postoperative setting, TMR using both holmium:
Figure 2. Typical digital recordings for lased and nonlased regions of segment length and left ventricular pressure at baseline, 1 h and 6 h
after TMR with a holmium:YAG laser in a representative animal. TMR 5 transmyocardial laser revascularization.
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YAG and CO2 lasers results in myocardial edema and
impaired diastolic relaxation in the lased regions. Secondly,
impaired regional systolic function, in association with
regional ischemia, is seen in the treated regions after TMR
with the holmium:YAG laser, but not the CO2 laser.
Laser-specific tissue effects. The word “laser” is an acro-
nym for light amplification by stimulated emission of
radiation, and laser systems are defined by their physical
parameters including wavelength, energy and pulse duration
(33,34). Carbon dioxide lasers operate at a wavelength of
10.6 mm, which is highly absorbed by water, whereas the
wavelength of holmium:YAG is 2.1 mm. This shorter
wavelength is much less absorbed by water. The CO2 laser,
because of its high coefficient of absorption, produces
relatively confined photothermal ablative effects in myocar-
dium with only a small zone of lateral thermal necrosis
Figure 3. Regional stroke work versus end-diastolic segment
length curves for the lased regions in representative animals
undergoing TMR with: (A) holmium:YAG and (B) CO2 lasers.
Note the rightward shift in the x-intercept representing diastolic
creep in the holmium:YAG lased regions. This rightward shift is
characteristic of ischemic myocardial dysfunction (22). Preload
recruitable work area was calculated from the area under these
curves for each individual animal. TMR 5 transmyocardial laser
revascularization. Closed diamond 5 baseline; open square 5 1 h
post-TMR; solid triangle 5 6 h post-TMR.
Figure 4. Preload recruitable work area for lased and nonlased
(control) regions after TMR with: (A) holmium:YAG and (B) CO2
lasers. Preload recruitable work area values are expressed as a percent
of baseline values in the lased and nonlased regions (normalized), with
baseline values assigned a value of 100%. Note the significant decrease
in PRWA for the lased regions at both 1 (59.8 6 13% baseline) and
6 h (64.2 6 9.4% baseline) after holmium:YAG TMR (absolute
PRWA values: baseline 1,882 6 283 erg-mm, 1 h 1,112 6 297
erg-mm, 6 h 1,182 6 214 erg-mm). No significant change in PRWA
for the lased regions was seen after CO2 laser TMR (1 h: 86.9 6
17.5% baseline; 6 h: 97.2 6 20.8% baseline) (absolute PRWA values:
baseline 1,001 6 238 erg-mm, 1 h 837 6 275 erg-mm, 6 h 789 6 98
erg-mm). Likewise, there was no change in PRWA for the nonlased
regions after TMR with either holmium:YAG (1 h: 97.0 6 27.6%
baseline; 6 h: 106.1 6 25.7% baseline) (absolute PRWA values:
baseline 1,175 6 246 erg-mm, 1 h 1,029 6 213 erg-mm, 6 h 1,153 6
234 erg-mm) or CO2 (1 h: 103.0 6 26.4% baseline; 6 h: 128.6 6
53.2% baseline) (absolute PRWA values: baseline 1,437 6 609
erg-mm, 1 h 786 6 247 erg-mm, 6 h 1,135 6 117 erg-mm) lasers.
PRWA 5 preload recruitable work area; TMR 5 transmyocardial
laser revascularization; holmium:YAG 5 holmium:yttrium-
aluminum-garnet. A: *p 5 0.02 vs. baseline; **p 5 0.02 vs. baseline.
Solid diamond 5 lased; open square 5 control.
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(30,33,34). Holmium:YAG lasers, on the other hand, work
via both photothermal and photoacoustic effects, are less
purely ablative and produce greater lateral thermal damage
than CO2 lasers (33,35). Based on the known tissue effects
of these lasers, one hypothesis to explain the findings of this
study is that the holmium:YAG laser, with its greater lateral
thermal damage, produced regional ischemia via coagulation
of myocardial arterioles and capillaries in the lased region
after absorption of peripheral laser energy (30). The CO2
laser, because of its more confined ablative effects, may have
produced less regional small vessel damage and, conse-
quently, no measurable change in regional MBF or systolic
function. As with holmium:YAG, the CO2 laser did pro-
duce enough tissue damage to lead to a significant increase
in tissue water content in the lased regions along with
impaired diastolic relaxation.
Perioperative cardiac morbidity post-TMR. Clinical
studies of TMR have noted a relatively high incidence of
cardiac complications in the early postoperative period
(1–8,13,17–19), with the majority of this morbidity occur-
ring in the first 24 h after surgery. Several authors
(5,8,13,19) have hypothesized that these adverse cardiac
events may stem from myocardial edema after the procedure
although this concept was previously unproven. In addition,
early postoperative myocardial ischemia has been noted to
occur relatively frequently post-TMR (18), and yet the
possibility of laser treatment as a potential cause of this
ischemia has not been described. Patients with preoperative
unstable angina and congestive heart failure (1,8,19) have
been noted to experience significantly greater post-TMR
morbidity and mortality than stable patients. Based on the
findings of this study, it seems logical that when laser
induced injury is superimposed on significant preexisting
left ventricular dysfunction, worsening heart failure with its
associated morbidity results. In addition, these findings
suggest that TMR with a holmium:YAG laser might be
expected to produce greater early postoperative cardiac
dysfunction than CO2 laser TMR due to the associated
changes in both systolic and diastolic function versus dia-
stolic dysfunction only with CO2. The published experience
with holmium:YAG TMR to date is relatively small (5,6)
compared with CO2 laser (1–4,7,8,13), and, consequently,
Figure 5. Representative regional steady-state pressure-strain re-
lations during diastole for the lased region in a single animal at
baseline, 1 h and 6 h post-TMR. Note the progressive leftward
shift in the pressure-strain relations, consistent with a decrease in
regional compliance after TMR. TMR 5 transmyocardial laser
revascularization.
Figure 6. Regional diastolic stiffness (a) for lased and nonlased
regions after TMR with (A) holmium:YAG and (B) CO2 lasers.
Values of a are expressed as a percent of baseline values in the lased
and nonlased regions (normalized), with baseline values assigned a
value of 100%. Higher values indicate increasing myocardial
stiffness. Note the significant increase in a, indicating impaired
diastolic relaxation in the lased regions by 6 h post-TMR with
both holmium:YAG (1 h: 183.3 6 56.3% baseline; 6 h: 217.4 6
44.2% baseline) (absolute a values: baseline 67.1 6 18.5, 1 h
84.4 6 10.8, 6 h 117.5 6 9.9) and CO2 (1 h: 112.4 6 24.7%
baseline; 6 h: 206.0 6 36.7% baseline) (absolute a values: baseline
65.3 6 17.3, 1 h 60.3 6 10.5, 6 h 120.1 6 22.8) lasers. There was
no change in a for the nonlased regions after either holmium:YAG
(1 h: 76.2 6 19.1% baseline; 6 h: 99.5 6 15.2% baseline) (absolute
a values: baseline 71.1 6 5.4, 1 h 53.9 6 15.6, 6 h 70.8 6 13.3)
or CO2 (1 h: 93.6 6 19.7% baseline; 6 h: 112.8 6 32.9% baseline)
(absolute a values: baseline 119.0 6 21.6, 1 h 104.2 6 20.9, 6 h
118.4 6 22.0) TMR. Closed diamond 5 lased; open square 5
control. A: *p 5 0.05 vs. baseline; B: *p 5 0.03 vs. baseline.
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it is too early to tell whether the findings of this study will
be reflected in the clinical setting. Finally, although the
holmium:YAG laser appears to affect systolic as well as
diastolic function in the early postoperative period, it is
unknown whether these changes will have any adverse
effects on the long-term functional outcome of the proce-
dure. The experience with the CO2 laser suggests that
short-term changes in diastolic function do not adversely
affect the clinical outcome and benefits of the procedure.
Randomized trials comparing the CO2 and holmium:YAG
lasers have not been performed, and further research in this
area is needed.
Implications for postoperative management. If the find-
ings of this study can be extrapolated to the human clinical
arena, one might anticipate that the use of perioperative
diuretic therapy may potentially minimize myocardial
edema and diastolic dysfunction. This is supported by a
recent study from our institution demonstrating improved
outcomes for TMR patients receiving a furosemide infusion
beginning in the immediate postoperative period (19). In
addition, a recent study found a mortality benefit for
patients with unstable angina and reduced ejection fraction
undergoing TMR who had an intra-aortic balloon pump
placed preoperatively (8), suggesting the balloon pump may
help compensate for transient laser-induced myocardial
ischemia and dysfunction. Whether the laser-induced dys-
function becomes clinically relevant likely depends on the
extent of myocardium lased and the functional status of the
nonlased areas and their potential to compensate for im-
paired function in the lased regions.
Study limitations. A limitation of this study is that TMR
was performed in normal myocardium rather than the
chronically ischemic conditions under which the tech-
nique is applied clinically. Prior work in infarcted human
myocardium has shown that higher laser energy was
required to produce lesions comparable in size to those in
normal tissue (36). Whether this also applies to the
chronically ischemic, yet viable, myocardium typically
treated with TMR is not known. However, histologic
findings, including the degree of collateral thermal dam-
age, after TMR are essentially identical in normal and
chronically ischemic myocardium (37), suggesting the
functional changes observed in this study might also be
expected to occur in chronically ischemic hearts. A
second limitation is that the time course of the observed
systolic and diastolic dysfunction was not studied. How-
ever, one might assume the laser induced injury to be
reversible given the period of functional decline observed
in human studies has peaked around 24 h postoperatively
and improved thereafter (8,13,18).
In summary, TMR with both holmium:YAG and CO2
lasers induces regional myocardial edema and diastolic
dysfunction in the early postoperative period. In addition,
TMR with a holmium:YAG laser causes regional systolic
dysfunction, possibly secondary to an associated reduc-
tion in MBF. These functional changes likely contribute
to the adverse cardiac events often observed after the
procedure. Aggressive perioperative medical regimens
aimed at reducing myocardial edema and ischemia may
help limit any associated morbidity occurring as a result
of laser induced injury. The impact of these observed
functional changes on angina relief and long-term out-
come are not known.
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Table 2. Transmural MBF* in Lased and Nonlased Regions 1 and 6 h post-TMR
Nonlased 1 h
Post-TMR
Lased 1 h
Post-TMR
Nonlased 6 h
Post-TMR
Lased 6 h
Post-TMR
Holmium:YAG 6.6 6 1.1 5.8 6 1.1† 6.0 6 0.9 4.9 6 0.5‡
CO2 8.0 6 1.0 8.0 6 0.8 8.5 6 1.3 8.1 6 1.2
*Myocardial blood flow expressed as ml/min/g dry tissue weight. †p 5 0.02 for lased versus nonlased regions; ‡p 5 0.01 for lased
versus nonlased regions.
CO2 5 carbon dioxide; holmium:YAG 5 holmium:yttrium-aluminum-garnet; MBF 5 myocardial blood flow; TMR 5
transmyocardial laser revascularization.
Table 3. Mean MWC in Lased and Nonlased Regions 6 h Post-TMR
% MWC Nonlased
Regions
% MWC Lased
Regions
%
Change
p
Value
Holmium:YAG 80.0 6 0.3 81.5 6 0.5 1.4 6 0.3 0.004
CO2 80.1 6 0.5 81.0 6 0.5 1.0 6 0.2 0.002
CO2 5 carbon dioxide; holmium:YAG 5 holmium:yttrium-aluminum-garnet; MWC 5 myocardial water content; TMR 5
transmyocardial laser revascularization.
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